Stock Market News

First Patient Dosed In Phase 3 REVEAL Study Of ION582 For Angelman Syndrome

wccwcc
Jun 24, 2025 - 08:30
 0  0
First Patient Dosed In Phase 3 REVEAL Study Of ION582 For Angelman Syndrome

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
wcc
wcc

Related Posts

These Fossil Fuels Stocks Rallied As Senate Passed Trump's Tax, Spending Plan

These Fossil Fuels Stocks Rallied As Senate Passed Trum...

wcc Jul 4, 2025  0  0

Apple scores big victory with 'F1,' but AI is still a major problem in Cupertino

Apple scores big victory with 'F1,' but AI is still a m...

wcc Jul 4, 2025  0  0

Soybeans Strength Continuing on Thursday AM

Soybeans Strength Continuing on Thursday AM

wcc Jul 4, 2025  0  0

Ethereum is powering Wall Street's future. The crypto scene at Cannes shows how far it's come

Ethereum is powering Wall Street's future. The crypto s...

wcc Jul 4, 2025  0  0

CNBC Daily Open: Divergence between official and ADP jobs reports reveals two labor markets

CNBC Daily Open: Divergence between official and ADP jo...

wcc Jul 4, 2025  0  0

Tax changes under Trump’s 'big beautiful' bill — in one chart

Tax changes under Trump’s 'big beautiful' bill — in one...

wcc Jul 4, 2025  0  0